| Name | Title | Contact Details |
|---|---|---|
Bob Klapish |
Chief Operating Officer | Profile |
Riverview Health is comprised of a full-service, 156-bed hospital in Noblesville, a 16-bed hospital in Westfield, as well as freestanding combined ER and urgent care facilities. Also included are more than 25 primary, immediate and specialty-care facilities in Hamilton County. Riverview Health provides comprehensive inpatient and outpatient services in more than 35 healthcare specialties and has been frequently recognized for its clinical and service excellence, including being named America`s 100 Best Hospitals for Orthopedic Surgery by Healthgrades and earning the Healthgrades Outstanding Patient Experience award. For more information on Riverview Health, visit riverview.org.Together, we provide comprehensive inpatient and outpatient services in more than 35 healthcare specialties—and have been frequently recognized for our clinical and service excellence. A wide range of services is provided at our main campus—located at 395 Westfield Rd. in Noblesville—including comprehensive care in heart & vascular, orthopedics, advanced emergency services and a vast array of women`s health services. As one of the largest employers in Hamilton County, Riverview Health employs more than 1,400 employees, thereby having a significant impact on the local economy. Riverview Health is owned by the county and does not receive tax dollars for operating expenses.
JSS Medical Research is a Westmount, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Eggleston Youth Ctr is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Exigent Group is a New Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.